Popular Articles

Men And Women Find Cosmetic Surgery Appealing When They Suffer Appearance-Based Rejection Sensitivity
Researchers have found that men and women who feel sensitive to rejection based on their physical appearance are more likely to express interest in having cosmetic surgery than those who are less sensitive to appearance-based rejection. This effect is particularly true when people recall negative comments about their physical appearance.
generic viagra online
ENT And Allergy Initiates A 'First Of Its Kind' Self-Insured Medical Malpractice Program
ENT and Allergy Associates, LLP (ENTA), is pleased to announce the formation of OASIS (i.e., Otolaryngology, Allergy Specialty Insurance Services), a separate company that will be a vehicle to provide Otolaryngology and Allergy Specific medical malpractice coverage. OASIS, which will be domiciled in the State of Vermont, is the first RRG to provide medical malpractice coverage exclusively to ENT physicians and Allergists. ENTA decided to embark on this path as a means of stabilizing its malpractice premiums in the face of mounting deficits among the State"s largest carriers and the failure of the legislature to pass any meaningful tort reform. These factors will most likely result in substantial premium increases well into the future. In addition, ENTA, now a 96 physician practice, will be able to focus on controlling the risks unique to its specialty to ensure patient safety and physician compliance with its risk management policies.
News of the day
Schering-Plough Announces U.S. Filing Of Mometasone Furoate/Formoterol Fumarate Combination For The Maintenance Treatment Of Asthma
Schering-Plough announced that a New Drug Application (NDA) for a fixed-dose combination of mometasone furoate and formoterol fumarate has been filed in the United States and accepted for review by the U.S. Food and Drug Administration (FDA). Schering-Plough is seeking marketing approval from the FDA of the mometasone furoate/formoterol fumarate combination for the maintenance treatment of asthma in patients 12 years of age and older.
Medical Devices

Latin America Must Cut Blood Pressure To Thrive

Combating high blood pressure is a global challenge. But while developed countries have enjoyed reductions in cardiovascular disease over recent decades, Latin America has been less fortunate. In fact new research published in the journal Therapeutic Advances in Cardiovascular Disease shows that high blood pressure is on the increase in many Latin American countries, a situation set to worsen unless immediate action is taken. Adolfo Rubinstein from Hospital Italiano de Buenos Aires, Luis Alcocer from Universidad Nacional Aut̚noma de M̩xico and Hospital General de M̩xico, and Antonio Chagas from University of Ṣo Paulo Medical School Heart Institute have detailed the evidence in their article High blood pressure in Latin America: a call to action, and offer specific recommendations to remedy the situation. Despite major healthcare problems in terms of equity and efficiency in the majority of Latin American countries, the overall health indicators of Latin America"s population have been on an upward trend over the last 50 years, a trend that continues today. Yet as life expectancy increases the most common health issues are shifting from dealing with acute disease to more expensive and complex chronic diseases. The chronic disease scenario is already common in developed countries, evidenced by the fact that cardiovascular disease makes up 11% of the global disease burden, leading to some 17.7 million deaths each year. Rapidly developing nations, like many in Latin America, still have a relatively high burden of infectious and communicable disease. The added increase in cardiovascular disease means these countries shoulder a "double burden" of disease. In fact experts have noted that middle- and low-income regions have a five-fold greater disease burden, but have access to less than one tenth of global treatment res. Increasing rates of hypertension and chronic diseases, coupled with expected increases in population growth, then, present a mounting threat to Latin American economies. "These dismal observations warrant a call to action for improved control of high BP and other cardiovascular risk factors across Latin America," says Alcocer. "Achieving these ambitious goals will require collaborative efforts by many groups, including policymakers, international organizations, healthcare providers, schools and society as a whole." The report provides a comprehensive overview of the burden of high blood pressure across Latin America, but "it alone cannot bring about change," say the authors. Accepting and instituting core policy changes are key to galvanize action, and results. In terms of core policy, regional policy makers must be alerted to the benefits of high blood pressure detection and control and make this a major public health priority. Leaders must provide res to empower and train health professionals to detect, diagnose, treat and control high blood pressure, and these must include effective drugs and interventions. It is vital to launch high blood pressure detection and management campaigns. Education and awareness promotion is another critical step, and must include healthy lifestyle advice, and explain the links to risk factors such as smoking and obesity. In treatment terms, policy makers must encourage therapeutic drug use based on clinical- and cost-effectiveness, acceptability, and affordability for Latin American countries. Healthcare professionals must manage high blood pressure in the context of other cardiovascular risk factors, and work to ensure treatment compliance and adherence. Government officials and others bearing the cost must be sold the benefits of campaigns to prevent, identify and treat hypertension. The authors also recommend more research, specifically studies that include Latin American patients in large, long-term, clinical-outcome and epidemiological studies to improve clinical outcomes in specific regional context. This research needs support in the form of funding, including patient-oriented acceptance and compliance issues within the Latin American context. SAGE Publications


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):